What improvements would you like in Yahoo! Finance Message Boards? Please send us feedback.
10/26/09 presentation...     26-Oct-09 02:08 pm    
http://cc.talkpoint.com/bcom001/102609a_...

Key Points...

1) LPATH has monopoly in bioactive lipids (i.e., ONLY LPATH has generated antibodies against bioactive lipids)

2) iSonep completed phase 1 for wet amd, well tolerated, no toxicity, (as we know from the published papers) Non-verlapping effects as well as overlapping effects with current treatment...

Results of Phase 1: About to be presented...


Sentiment : Strong Buy
Rating :
 (No ratings)
Rate it:
awful/not related to \pooraveragegoodexcellent

tdeank

37


View Messages

Ignore User

Report Abuse

< Previous Message |   Next Message >
View: Simple | Summary | Expanded
As: Threaded | Msg List
Page 1 of about 1   First | < Prev | Next > | Last

Messages in Topic

Minimum rating: What's this?
  Subject Author Rating Time of Post (ET)  
 
10/26/09 presentation...
tdeank Not rated 26-Oct-09 02:08 pm  
 
Phase 1 Results of iSONEP... 1) Drug well toler...
tdeank Rate it 26-Oct-09 02:15 pm  
 
ASONEP results...(in expansion cohort, 7 new ...
tdeank Rate it 26-Oct-09 02:19 pm  
 
Great recap T, Hope this presentation...
shreditnow Rate it 26-Oct-09 03:43 pm  
View: Simple | Summary | Expanded
As: Threaded | Msg List
Page 1 of about 1   First | < Prev | Next > | Last

Lpath Inc. (LPTN.OB)

Chart for Lpath Inc. (LPTN.OB)
On Dec 21: 0.75 Up 0.06 (8.70%)
Symbol Lookup